This study is in progress, not accepting new patients
A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Agios Pharmaceuticals, Inc.
- ID
- NCT03692052
- Phase
- Phase 2 Thalassemia Research Study
- Study Type
- Interventional
- Participants
- About 20 people participating
- Last Updated